Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - REVENUE
Revenue APLS - Apellis Pharmaceuticals, Inc.
397 M
LAST VALUE
144.09%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR